The integration of 18-fluoro-deoxy-glucose positron emission tomography and endoscopic ultrasound in the treatment-planning process for esophageal carcinoma
- 15 March 2005
- journal article
- research article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 61 (4) , 1123-1128
- https://doi.org/10.1016/j.ijrobp.2004.07.717
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- The ability of whole body FDG18 PET imaging to predict pathologic response to induction chemoradiotherapy in locally advanced esophageal cancer. A prospective phase II trialInternational Journal of Radiation Oncology*Biology*Physics, 2003
- Whole Body 18FDG-PET and the Response of Esophageal Cancer to Induction Therapy: Results of a Prospective TrialJournal of Clinical Oncology, 2003
- Positron Emission Tomography in the Initial Staging of Esophageal CancerArchives of Surgery, 2002
- Length of Esophageal Cancer and Degree of Luminal Stenosis during Upper Endoscopy Predict T stage by Endoscopic UltrasoundEndoscopy, 2002
- Correlation of EUS measurement with pathologic assessment of neoadjuvant therapy response in esophageal carcinomaGastrointestinal Endoscopy, 2002
- Influence of Staging Thoracic Computed Tomography on Radiation Therapy Planning for Esophageal CarcinomaJournal of Thoracic Imaging, 2002
- Positron emission tomography for assessment of the response to induction radiochemotherapy in locally advanced oesophageal cancerAnnals of Oncology, 2002
- Single-photon emission computed tomography and positron-emission tomography assays for tissue oxygenationSeminars in Radiation Oncology, 2001
- Imaging Features of Primary and Recurrent Esophageal Cancer at FDG PETRadioGraphics, 2000
- Evaluation of 18F-FDG positron emission tomography in gastric and oesophageal carcinoma.The British Journal of Radiology, 1999